top of page
Innovating In Vivo CAR T Therapy
for autoimmune disease

Revolutionizing Immunotherapy with

Direct In Vivo CAR T Cell Engineering

Pipeline

Program

GRG07 (CD19)

Cell Type

T cells

Potential Indications

Autoimmune Diseases
 

  • Scleroderma

  • Lupus

  • Extrarenal SLE

Discovery

bottom of page